It has been shown that IGFBP-2 is able to exert intrinsic effects on a Ewing sarcoma, and on a breast cancer, cell line by binding to cell surfaces through its RGD recognition sequence (Schutt et al, 2004). Here, IGFBP2 is linked to breast carcinoma.